Macrolides As Empiric Therapy for Outpatients With Pneumonia
Overview
Overview
Journal
Open Forum Infect Dis
Specialty
Infectious Diseases
Date
2021 Jul 12
PMID
34250182
Citations
2
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Trends in Antimicrobial Resistance in US Children: A Multicenter Evaluation.
Mohanty S, Feemster K, Yu K, Watts J, Gupta V Open Forum Infect Dis. 2023; 10(3):ofad098.
PMID: 36968964 PMC: 10034583. DOI: 10.1093/ofid/ofad098.
Mohanty S, Johnson K, Yu K, Watts J, Gupta V Open Forum Infect Dis. 2022; 9(9):ofac420.
PMID: 36168549 PMC: 9511122. DOI: 10.1093/ofid/ofac420.
References
1.
Jain S, Self W, Wunderink R, Fakhran S, Balk R, Bramley A
. Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults. N Engl J Med. 2015; 373(5):415-27.
PMC: 4728150.
DOI: 10.1056/NEJMoa1500245.
View
2.
Gupta V, Yu K, Schranz J, Gelone S
. A Multicenter Evaluation of the US Prevalence and Regional Variation in Macrolide-Resistant in Ambulatory and Hospitalized Adult Patients in the United States. Open Forum Infect Dis. 2021; 8(7):ofab063.
PMC: 8266646.
DOI: 10.1093/ofid/ofab063.
View
3.
Jones R, Jacobs M, Sader H
. Evolving trends in Streptococcus pneumoniae resistance: implications for therapy of community-acquired bacterial pneumonia. Int J Antimicrob Agents. 2010; 36(3):197-204.
DOI: 10.1016/j.ijantimicag.2010.04.013.
View
4.
Musher D, Roig I, Cazares G, Stager C, Logan N, Safar H
. Can an etiologic agent be identified in adults who are hospitalized for community-acquired pneumonia: results of a one-year study. J Infect. 2013; 67(1):11-8.
PMC: 7132393.
DOI: 10.1016/j.jinf.2013.03.003.
View
5.
File T, Goldberg L, Das A, Sweeney C, Saviski J, Gelone S
. Efficacy and Safety of Intravenous-to-oral Lefamulin, a Pleuromutilin Antibiotic, for the Treatment of Community-acquired Bacterial Pneumonia: The Phase III Lefamulin Evaluation Against Pneumonia (LEAP 1) Trial. Clin Infect Dis. 2019; 69(11):1856-1867.
PMC: 6853694.
DOI: 10.1093/cid/ciz090.
View